4.4 Article

Pharmacokinetic study of puerarin in rat serum by liquid chromatography tandem mass spectrometry

期刊

BIOMEDICAL CHROMATOGRAPHY
卷 21, 期 4, 页码 410-414

出版社

WILEY
DOI: 10.1002/bmc.772

关键词

puerarin; pharmacokinetics; serum; rats; LC-MS/MS

资金

  1. NCCIH NIH HHS [P50 AT-00477] Funding Source: Medline
  2. NCI NIH HHS [P30 CA-13148] Funding Source: Medline
  3. NCRR NIH HHS [S10 RR-06487, RR-19231] Funding Source: Medline

向作者/读者索取更多资源

A highly sensitive and specific atmospheric pressure chemical ionization liquid chromatography-tandem mass spectrometry method was developed for serum pharmacokinetic studies of puerarin in rats. Chromatography was carried out on a reversed-phase Phenomenex Synergi 4 mu m Fusion-RP80 column (150 x 2.0 mm W.) using a mobile phase consisting of acetonitrile-water (10:90, v/v) in 10 mM NH4OAc with a flow rate of 0.2 mL/min. Puerarin was analyzed in the multiple reaction monitoring mode with a precursor/product ion transition of m/z 415/267. The method was demonstrated to be specific and sensitive, and a linear response was observed over a range of 2-5000 ng/mL in rat serum. The validated method was successfully applied to the characterization of the pharmacokinetics of puerarin in rat serum after oral administration to spontaneously hypertensive rats. The blood concentration-time profile of puerarin showed a rapid initial increase, reaching a maximum and then declining within 1 h. Puerarin could not be detected after 24 h. The main pharmacokinetic parameters for puerarin after oral administration were as follows: C-max (3.54 +/- 2.03 mg/L), T-max (0.68 +/- 0.37 h), AUC(0-1) (7.29 +/- 3.79 mg h/L), AUC(0-infinity) (9.17 +/- 4.87 mg h/L), T-1/2 (1.7 +/- 0.6 h), CL/F (7.24 +/- 4.27 L/h/kg) and V/F (17.88 +/- 13.55 L/h/kg). Copyright (c) 2007 John Wiley & Sons, Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据